Slideshow

You Spoke, We Listened. Psychiatry's Cannabis Survey

Author(s):

Psychiatric Times Editors

Enlightening survey results reveal what psychiatrists think about medical marijuana/cannabis use, how or whether to discuss with their patients, and what biases might get in the way of such conversations.

Related Videos
schizophrenia
clozapine
brain
Andrii Yalaanskyi/AdobeStock
Africa Studio/AdobeStock
VectorStory/AdobeStock
Julyuela/AdobeStock
Michael/AdobeStock
Cendece_AdobeStock
Related Content
brain
April 23rd 2025

Transneural Therapeutics: A New Company to Develop Novel Neuroplastogens

Leah Kuntz
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
benzodiazepine
April 16th 2025

Benzodiazepine Discontinuation Associated With Increased Mortality in Patients on Stable, Long-Term Benzodiazepines

Geena Sutherland, MD Nancy Kartiko, MD Haley Schuster, MD Mark Mullen, MD Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP
How to Talk to Teenagers About Substance Use
October 8th 2021

How to Talk to Teenagers About Substance Use

Hannah Simon, MD
female prisoner
April 7th 2025

Female Offenders: Patterns, Risk, and Assessment

Anne-Marie Hathaway, DO
smoking
March 27th 2025

In Schizophrenia, Nicotine Enhances Cognitive Performance by Improving Brain Network Function

Heather Burrell Ward, MD
© 2025 MJH Life Sciences

All rights reserved.